ImmunoPrecise Increases Financing to $2.3 Million and Makes Payment in Respect of Deferred Purchase Price for IPA Europe and Immulease
Stock Information for Immunoprecise Antibodies Ltd.
Loading
Please wait while we load your information from QuoteMedia.